annual net income:
$11.94B-$2.91B(-19.59%)Summary
- As of today (April 16, 2025), NVS annual net profit is $11.94 billion, with the most recent change of -$2.91 billion (-19.59%) on December 31, 2024.
- During the last 3 years, NVS annual net income has fallen by -$12.08 billion (-50.29%).
- NVS annual net income is now -50.29% below its all-time high of $24.02 billion, reached on December 31, 2021.
Performance
NVS Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
$2.82B-$371.00M(-11.63%)Summary
- As of today (April 16, 2025), NVS quarterly net profit is $2.82 billion, with the most recent change of -$371.00 million (-11.63%) on December 31, 2024.
- Over the past year, NVS quarterly net income has dropped by -$428.00 million (-13.19%).
- NVS quarterly net income is now -82.72% below its all-time high of $16.31 billion, reached on December 31, 2021.
Performance
NVS quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
$11.94B-$5.66B(-32.16%)Summary
- As of today (April 16, 2025), NVS TTM net profit is $11.94 billion, with the most recent change of -$5.66 billion (-32.16%) on December 31, 2024.
- Over the past year, NVS TTM net income has dropped by -$4.23 billion (-26.18%).
- NVS TTM net income is now -50.62% below its all-time high of $24.18 billion, reached on March 31, 2022.
Performance
NVS TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
NVS Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.6% | -13.2% | -26.2% |
| 3 y3 years | -50.3% | +79.2% | -45.2% |
| 5 y5 years | +1.8% | +50.9% | +65.6% |
NVS Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -50.3% | +71.7% | -66.8% | +92.2% | -50.6% | +71.7% |
| 5 y | 5-year | -50.3% | +71.7% | -82.7% | +92.2% | -50.6% | +71.7% |
| alltime | all time | -50.3% | +211.3% | -82.7% | +348.0% | -50.6% | +849.2% |
Novartis AG Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $11.94B(-19.6%) | $2.82B(-11.6%) | $11.94B(-32.2%) |
| Sep 2024 | - | $3.19B(-1.8%) | $17.60B(+8.8%) |
| Jun 2024 | - | $3.25B(+20.8%) | $16.18B(+6.1%) |
| Mar 2024 | - | $2.69B(-68.3%) | $15.24B(+2.7%) |
| Dec 2023 | $14.85B(+113.5%) | $8.48B(+381.5%) | $14.85B(+89.5%) |
| Sep 2023 | - | $1.76B(-24.0%) | $7.84B(+2.5%) |
| Jun 2023 | - | $2.32B(+1.0%) | $7.65B(+8.9%) |
| Mar 2023 | - | $2.29B(+56.4%) | $7.03B(+1.0%) |
| Dec 2022 | $6.96B(-71.0%) | $1.47B(-6.8%) | $6.96B(-68.1%) |
| Sep 2022 | - | $1.57B(-7.1%) | $21.80B(-5.2%) |
| Jun 2022 | - | $1.69B(-23.8%) | $22.98B(-5.0%) |
| Mar 2022 | - | $2.22B(-86.4%) | $24.18B(+0.7%) |
| Dec 2021 | $24.02B(+197.6%) | $16.31B(+491.3%) | $24.02B(+144.9%) |
| Sep 2021 | - | $2.76B(-4.8%) | $9.81B(+9.2%) |
| Jun 2021 | - | $2.90B(+40.7%) | $8.98B(+12.9%) |
| Mar 2021 | - | $2.06B(-1.7%) | $7.96B(-1.4%) |
| Dec 2020 | $8.07B(-31.2%) | $2.09B(+8.2%) | $8.07B(+13.6%) |
| Sep 2020 | - | $1.94B(+3.6%) | $7.10B(-1.5%) |
| Jun 2020 | - | $1.87B(-14.2%) | $7.21B(-40.6%) |
| Mar 2020 | - | $2.18B(+93.4%) | $12.14B(+3.5%) |
| Dec 2019 | $11.73B(-7.0%) | $1.13B(-44.9%) | $11.73B(-0.6%) |
| Sep 2019 | - | $2.04B(-70.0%) | $11.80B(+3.7%) |
| Jun 2019 | - | $6.80B(+285.0%) | $11.38B(-7.8%) |
| Mar 2019 | - | $1.77B(+47.8%) | $12.35B(-2.1%) |
| Dec 2018 | $12.61B(+63.7%) | $1.20B(-26.4%) | $12.61B(-5.8%) |
| Sep 2018 | - | $1.62B(-79.1%) | $13.39B(-3.3%) |
| Jun 2018 | - | $7.77B(+283.6%) | $13.85B(+71.8%) |
| Mar 2018 | - | $2.02B(+2.5%) | $8.06B(+4.7%) |
| Dec 2017 | $7.70B(+14.8%) | $1.98B(-5.0%) | $7.70B(+15.2%) |
| Sep 2017 | - | $2.08B(+5.1%) | $6.68B(+2.2%) |
| Jun 2017 | - | $1.98B(+18.8%) | $6.54B(+2.8%) |
| Mar 2017 | - | $1.67B(+74.1%) | $6.37B(-5.1%) |
| Dec 2016 | $6.71B(-62.3%) | $957.00M(-50.7%) | $6.71B(-1.4%) |
| Sep 2016 | - | $1.94B(+7.5%) | $6.81B(+0.8%) |
| Jun 2016 | - | $1.80B(-10.3%) | $6.76B(-0.5%) |
| Mar 2016 | - | $2.01B(+90.8%) | $6.79B(-61.8%) |
| Dec 2015 | $17.78B(+74.2%) | $1.05B(-44.2%) | $17.78B(-2.4%) |
| Sep 2015 | - | $1.89B(+2.8%) | $18.22B(-6.8%) |
| Jun 2015 | - | $1.84B(-85.9%) | $19.55B(-3.5%) |
| Mar 2015 | - | $13.01B(+772.2%) | $20.27B(+98.6%) |
| Dec 2014 | $10.21B(+11.3%) | $1.49B(-53.7%) | $10.21B(-5.0%) |
| Sep 2014 | - | $3.22B(+26.1%) | $10.75B(+10.2%) |
| Jun 2014 | - | $2.56B(-13.1%) | $9.76B(+0.4%) |
| Mar 2014 | - | $2.94B(+44.9%) | $9.72B(+5.9%) |
| Dec 2013 | $9.18B(-1.0%) | $2.03B(-9.1%) | $9.18B(+0.5%) |
| Sep 2013 | - | $2.23B(-11.3%) | $9.13B(-1.7%) |
| Jun 2013 | - | $2.52B(+4.9%) | $9.29B(-1.4%) |
| Mar 2013 | - | $2.40B(+20.8%) | $9.42B(+1.6%) |
| Dec 2012 | $9.27B | $1.99B(-16.9%) | $9.27B(+11.9%) |
| Sep 2012 | - | $2.39B(-9.7%) | $8.29B(-0.9%) |
| Jun 2012 | - | $2.65B(+17.8%) | $8.36B(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $2.25B(+124.3%) | $8.42B(-5.9%) |
| Dec 2011 | $8.94B(-8.7%) | $1.00B(-59.3%) | $8.94B(-11.5%) |
| Sep 2011 | - | $2.46B(-8.9%) | $10.11B(+1.9%) |
| Jun 2011 | - | $2.70B(-2.4%) | $9.92B(+3.0%) |
| Mar 2011 | - | $2.77B(+27.7%) | $9.63B(-1.7%) |
| Dec 2010 | $9.79B(+16.6%) | $2.17B(-4.7%) | $9.79B(-1.4%) |
| Sep 2010 | - | $2.27B(-5.9%) | $9.93B(+1.8%) |
| Jun 2010 | - | $2.42B(-17.6%) | $9.75B(+4.1%) |
| Mar 2010 | - | $2.93B(+27.2%) | $9.37B(+11.6%) |
| Dec 2009 | $8.40B(+2.5%) | $2.31B(+9.9%) | $8.40B(+10.0%) |
| Sep 2009 | - | $2.10B(+3.1%) | $7.63B(+0.1%) |
| Jun 2009 | - | $2.04B(+3.7%) | $7.63B(-2.7%) |
| Mar 2009 | - | $1.96B(+27.5%) | $7.84B(-4.3%) |
| Dec 2008 | $8.20B(-31.4%) | $1.54B(-26.4%) | $8.20B(+8.4%) |
| Sep 2008 | - | $2.09B(-7.1%) | $7.56B(-38.7%) |
| Jun 2008 | - | $2.25B(-2.9%) | $12.34B(+2.0%) |
| Mar 2008 | - | $2.32B(+156.3%) | $12.09B(+1.2%) |
| Dec 2007 | $11.95B(+66.5%) | $904.00M(-86.8%) | $11.95B(-5.9%) |
| Sep 2007 | - | $6.87B(+241.9%) | $12.70B(+64.9%) |
| Jun 2007 | - | $2.01B(-7.4%) | $7.70B(+4.1%) |
| Mar 2007 | - | $2.17B(+31.1%) | $7.40B(+3.1%) |
| Dec 2006 | $7.17B(+17.0%) | $1.65B(-11.4%) | $7.17B(+4.4%) |
| Sep 2006 | - | $1.87B(+9.4%) | $6.87B(+3.1%) |
| Jun 2006 | - | $1.71B(-12.3%) | $6.66B(+0.9%) |
| Mar 2006 | - | $1.95B(+44.2%) | $6.60B(+7.6%) |
| Dec 2005 | $6.13B(+14.3%) | $1.35B(-18.6%) | $6.14B(+6.5%) |
| Sep 2005 | - | $1.66B(+0.8%) | $5.76B(+2.0%) |
| Jun 2005 | - | $1.65B(+11.1%) | $5.65B(+1.7%) |
| Mar 2005 | - | $1.48B(+51.7%) | $5.55B(+3.5%) |
| Dec 2004 | $5.37B(+13.1%) | $976.00M(-36.9%) | $5.37B(-2.0%) |
| Sep 2004 | - | $1.55B(-0.1%) | $5.48B(+5.2%) |
| Jun 2004 | - | $1.55B(+19.8%) | $5.21B(+4.7%) |
| Mar 2004 | - | $1.29B(+19.0%) | $4.97B(+4.8%) |
| Dec 2003 | $4.74B(+0.4%) | $1.09B(-14.9%) | $4.74B(-1.9%) |
| Sep 2003 | - | $1.28B(-3.0%) | $4.83B(+3.6%) |
| Jun 2003 | - | $1.32B(+23.8%) | $4.67B(-1.6%) |
| Mar 2003 | - | $1.06B(-9.8%) | $4.75B(-0.6%) |
| Dec 2002 | $4.72B(+23.2%) | $1.18B(+6.1%) | $4.77B(+13.0%) |
| Sep 2002 | - | $1.11B(-20.2%) | $4.22B(-0.4%) |
| Jun 2002 | - | $1.39B(+27.7%) | $4.24B(+9.1%) |
| Mar 2002 | - | $1.09B(+73.3%) | $3.89B(+0.5%) |
| Dec 2001 | $3.84B(-14.1%) | $629.00M(-44.2%) | $3.87B(-12.2%) |
| Sep 2001 | - | $1.13B(+8.6%) | $4.40B(+6.1%) |
| Jun 2001 | - | $1.04B(-3.0%) | $4.15B(-5.5%) |
| Mar 2001 | - | $1.07B(-8.0%) | $4.39B(-4.1%) |
| Dec 2000 | $4.47B(+6.8%) | $1.16B(+32.9%) | $4.58B(+34.1%) |
| Sep 2000 | - | $876.00M(-31.7%) | $3.42B(+34.5%) |
| Jun 2000 | - | $1.28B(+1.9%) | $2.54B(+101.9%) |
| Mar 2000 | - | $1.26B | $1.26B |
| Dec 1999 | $4.18B(-4.3%) | - | - |
| Dec 1998 | $4.37B | - | - |
FAQ
- What is Novartis AG annual net profit?
- What is the all time high annual net income for Novartis AG?
- What is Novartis AG annual net income year-on-year change?
- What is Novartis AG quarterly net profit?
- What is the all time high quarterly net income for Novartis AG?
- What is Novartis AG quarterly net income year-on-year change?
- What is Novartis AG TTM net profit?
- What is the all time high TTM net income for Novartis AG?
- What is Novartis AG TTM net income year-on-year change?
What is Novartis AG annual net profit?
The current annual net income of NVS is $11.94B
What is the all time high annual net income for Novartis AG?
Novartis AG all-time high annual net profit is $24.02B
What is Novartis AG annual net income year-on-year change?
Over the past year, NVS annual net profit has changed by -$2.91B (-19.59%)
What is Novartis AG quarterly net profit?
The current quarterly net income of NVS is $2.82B
What is the all time high quarterly net income for Novartis AG?
Novartis AG all-time high quarterly net profit is $16.31B
What is Novartis AG quarterly net income year-on-year change?
Over the past year, NVS quarterly net profit has changed by -$428.00M (-13.19%)
What is Novartis AG TTM net profit?
The current TTM net income of NVS is $11.94B
What is the all time high TTM net income for Novartis AG?
Novartis AG all-time high TTM net profit is $24.18B
What is Novartis AG TTM net income year-on-year change?
Over the past year, NVS TTM net profit has changed by -$4.23B (-26.18%)